Ellen Goldmuntz - Concepedia

Author

Ellen Goldmuntz

Also Known As

E A Goldmuntz, E Goldmuntz, E. A. Goldmuntz, E. Goldmuntz, E.A. Goldmuntz, Ellen A. Goldmuntz, Ellen Goldmuntz, Harry L Gewanter, John Peyman, William T Barry

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Allergy and Infectious Diseases Rho (United States)University of California, Los Angeles

About

Ellen Goldmuntz is an author at National Institutes of Health specializing in medicine, immunology, and chromosome biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	1.2K
2	Allergy	3	3	135
3	Cell Biology	2	2	122
4	Health Sciences	1	1	17
5	Social Sciences	1	1	53

Ellen Goldmuntz

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, New England Journal of Medicine	2018	567
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome Alexei A. Grom, Joyce Villanueva, Susan Lee, The Journal of Pediatrics InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseImmunology	2003	276
Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. Leslie J. Crofford, Hajime Sano, Katia Karalis, Journal of Clinical Investigation ImmunologyLewis RatsGlucocorticoidInflammatory ArthritisSubstance P	1992	207
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts Elizabeth R. Volkmann, Donald P. Tashkin, Myung‐Shin Sim, Annals of the Rheumatic Diseases	2018	193
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial Roham T. Zamanian, David B. Badesch, Robyn T. Domsic, American Journal of Respiratory and Critical Care Medicine	2021	172
The effect of norepinephrine on endotoxin-mediated macrophage activation Xiaoxi Hu, Ellen Goldmuntz, Celia F. Brosnan Journal of Neuroimmunology InflammationCytokineImmunologyEndotoxin-mediated Macrophage ActivationMedicine	1991	117
Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis. Hajime Sano, Kurt A. Engleka, P. Mathern, Journal of Clinical Investigation Aa ArthritisPhosphotyrosine-containing ProteinsImmunologyPathologyPsoriatic Arthritis	1993	88
Randomized, Double‐Blind, Placebo‐Controlled Trial of the Effect of Vitamin D<sub>3</sub> on the Interferon Signature in Patients With Systemic Lupus Erythematosus Cynthia Aranow, Diane L. Kamen, Maria Dall’Era, Arthritis & Rheumatology	2015	86
Prazosin, an alpha 1-adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat. Celia F. Brosnan, Ellen Goldmuntz, Wendy Cammer, Proceedings of the National Academy of Sciences Vascular PermeabilityAdrenal GlandAutoimmune DiseaseAllergyImmunotherapy	1985	81
Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial Emily W. Hung, Maureen D. Mayes, Roozbeh Sharif, The Journal of Rheumatology	2013	77

Page 1